Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02713516 · ClinicalTrials.gov registry record · NA

Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD

A NA study of Anxiety and Obsessive - Compulsive Disorder, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT02713516 is a NA study of Anxiety and Obsessive - Compulsive Disorder that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02713516, a NA study of Anxiety and Obsessive - Compulsive Disorder, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Cognitive Behavioral Therapy with fear provoking exposures is the most effective therapy for anxiety disorders. Investigators aim to enhance this therapy with the use of virtual reality exposures and to make therapy more available and accessible for patients with anxiety disorders. The societal benefit of increased access to therapy is that, if successful, it will increase the number of patients who receive appropriate treatment for an anxiety disorder.

Interventions

  • OTHER Virtual Reality

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-08-01
Est. Completion 2018-05-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT02713516

The ClinicalTrials.gov registry entry for NCT02713516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality is the first listed.

NCT02713516 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02713516 about?

NCT02713516 is a clinical study titled "Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD". Cognitive Behavioral Therapy with fear provoking exposures is the most effective therapy for anxiety disorders. Investigators aim to enhance this therapy with the use of virtual reality exposures and to make therapy more available and accessible for patients with anxiety disorders. The societal bene...

What is the current status of trial NCT02713516?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-08-01. Estimated completion is 2018-05-31.

What conditions does trial NCT02713516 study?

This clinical trial studies the following conditions: Anxiety, Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT02713516?

The interventions under investigation include: Virtual Reality (OTHER).

Who is sponsoring clinical trial NCT02713516?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02713516 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.